Cipla and Dr Reddys Lab receives FDA nod for marketing of generic version of REVLIMID (lenalidomide) Capsules. Both companies have received final approval of its Abbreviated New Drug Application (ANDA) for Lenalidomide Capsules.

With this volume-limited launch, Dr. Reddy’s Lab is eligible for first-to- market, 180 days of generic drug exclusivity for Lenalidomide Capsules in 2.5 mg and 20 mg strengths.

Regarding direct recruitment to various semi-medical posts in the remaining basic cadre in the Department of Health and Family Welfare.  Government Notification No.: HFW/709/HSM/2017, Dated: 17.05.2022, Karnataka Health and Family Welfare Department is inviting various semi-medical vacancies to be filled up by the candidates on the website.

Post : Pharmacy Officer * / Pharmacist

On obtaining the approval of the Hon’ble Health Minister & Secretary (Health)/Mission Director NHM. It is proposed to fill up the following categories of posts purely on Contract basis for a period of one year under National Health Mission (NHM), Directorate of Health Services, Panaji – Goa.

Post : Pharmacist (RBSK/AYUSH) North Goa ; South Goa

No of posts : 10

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conduct innovative translational research and to develop research collaborations across disciplines and professions to translate concepts into products to improve human health.

The Centre for Integrative Medicine and Research is a pioneering initiative by AIIMS, New Delhi in the quest for convergence of contemporary medicine with India’s ancient and traditional medical practices. The centre at the premier institute of the country shall be dedicated to research, documentation and delivery of holistic healthcare.

Researchers at McMaster University have discovered a previously unknown bacteria-killing toxin that could pave the way for a new generation of antibiotics.

The study, led by John Whitney at the Michael G. DeGroote Institute for Infectious Disease Research, shows that the bacterial pathogen Pseudomonas aeruginosa, known to cause hospital-acquired infections such as pneumonia, secretes a toxin that has evolved to kill other species of bacteria.

A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after third dose of the Pfizer-BioNTech COVID-19 vaccine, and the cases were rare and mild, according to new research published today in the American Heart Association’s flagship journal Circulation.

AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in China to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease (ESKD), cardiovascular (CV) death and hospitalisation for heart failure (hHF) in adults with chronic kidney disease (CKD) at risk of progression with and without type-2 diabetes (T2D).

Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health. Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement.

Lupin and DKSH have signed an exclusive license and supply agreement to commercialize five of Alvotechs proposed biosimilars in the Philippines. The biosimilars planned under this agreement include biosimilar Prolia, Xgeva, Simponi, and Eylea as well as two undisclosed proposed biosimilars for immunology and oncology.

Aizant is an integrated drug development solutions provider. Aizant was established by experienced pharmaceutical professionals with global exposure. We are a rapidly growing formulation CDMO and CRO with a diverse portfolio of capabilities partnering with health care companies specializing in new molecular entities (NMEs), generics (ANDAs) and over the counter (OTCs) products globally.

Post : Executive / Senior Executive

Vee Technologies is a premier consulting and professional services company, offering cutting-edge solutions to organizations around the world. With a powerful blend of people, processes and groundbreaking technology-enabled solutions, we streamline operations, increase cash flow, reduce costs and maximize compliance while providing an edge over the competition.

Post : Medical Coder / Sr. Medical Coder / QA / TL

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen.

Eisai Pharmaceuticals India is a 100 % subsidiary company of Eisai. Co.Ltd Japan and is a human health care company. Eisai India’s main manufacturing is in the integrated campus at Visakhapatnam, Andhra Pradesh. This facility is used to manufacture, package and perform testing for oral solid dosage products. Eisai India’s manufacturing site is part of Eisai’s global production structure to ensure a stable supply of high-quality products.

Vital Pharma is an endeavour to offer trustworthy partnership comprising superior quality products and services par excellence in Contract Manufacturing, Animal Nutrition, Human Nutrition, Aquaculture and Vitamin pre-mixes. Vital Therapeutics & Formulations is designed to meet International Regulatory requirements such as CGMP, WHO, ISO 9001 & FSSC 22000 and recognised for abiding to vigorous quality and service standards for product development, analytical services, packaging and regulatory services.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

The Origin of the Public Service Commission in India is found in the First Dispatch of the Government of India on Indian Constitutional Reforms on March 5, 1919 which referred to the need for setting up some permanent office charged with the regulation of service matters. This concept of a body intended to be charged primarily with the regulation of service matters, found a somewhat more practical shape in the Government of India Act, 1919. Section 96C of the Act provided for the establishment in India of a Public Service Commission which should discharge.

 Applications are invited from the candidates for post of Pharmacist on contract basis by DMFT, Hazaribagh

The last date for submission of application is -15.09.2022.  The application form can be sent through registered post and speed post to the office of Civil Surgeon-cum-Chief Medical Officer, Hazaribagh.  Applications received after the said date will not be considered.

Post : Pharmacist

​​CDSCO has approved a recombinant nasal vaccine for COVID-19 for restricted use in emergency situations.It is a recombinant replication deficient adenovirus vectored vaccine with a prefusion stabilised spike protein.

Dr Mansukh Mandaviya Minister of Health and Family Welfare informed today that Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by CDSCO for primary immunization against COVID-19 in 18 plus age group for restricted use in emergency situation.